Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
New breast cancer therapy study findings recently were published by researchers at Korea University, Department of Internal Medicine
February 1st, 2007
Data detailed in "Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer" have been presented. In this recently published study, investigators in Seoul, Korea conducted a study "To determine the safety and efficacy of gemcitabine and cisplatin in patients with taxane resistant metastatic breast cancer. Thirty-three taxane resistant metastatic breast cancer patients were treated with gemcitabine 1,250 mg/m2 IV infusion over 30 min on days 1 and 8, and with cisplatin 75 mg/m2 by IV infusion over 1 h on day 1 in 21 day cycles. Of the 30 evaluable patients, there were 9 (30%) partial responses and no complete response, an overall...
Source: Women's Health Weekly (2007-02-01)
|
|
Advertisement |
|
|
|
